Inhibition of [3H]platelet activating factor (PAF) binding by Zn2+: A possible explanation for its specific PAF antiaggregating effects in human platelets☆
References (40)
- et al.
J. Biol. Chem
(1979) - et al.
J. Biol. Chem
(1983) - et al.
Arch. Biochem. Biophys
(1988) - et al.
Prostaglandins Med
(1979) - et al.
Eur. J. Pharmacol
(1986) - et al.
Arch. Biochem. Biophys
(1986) - et al.
Eur. J. Pharmacol
(1987) - et al.
J. Biol. Chem
(1987) - et al.
Biochem. Biophys. Res. Commun
(1985) Thromb. Res
(1987)
J. Biol. Chem
(1988)
Biochim. Biophys. Acta
(1980)
Brain Res
(1982)
Brain Res
(1985)
Life Sci
(1986)
FEBS Lett
(1988)
Biochem. Biophys. Res. Commun
(1988)
Biochem. Pharmacol
(1986)
C. R. Acad. Sci. Paris
(1979)
Med. Res. Rev
(1985)
Cited by (18)
Platelet-activating factor receptor
2007, xPharm: The Comprehensive Pharmacology ReferencePhysiological roles of zinc in the plasma membrane of mammalian cells
1993, The Journal of Nutritional BiochemistryThe human platelet as a reproducible and sensitive cell for the detection and assay of platelet-activating factor
1992, Analytical BiochemistryStructural insights into galanin receptor signaling
2022, Proceedings of the National Academy of Sciences of the United States of America
- ☆
Supported by Grant AQ-887 from the Robert A. Welch Foundation.
Copyright © 1989 Published by Elsevier Inc.